Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non‐Small Cell Lung Cancer by Ori Aslan, Johnathan Arnon, Itamar Averbuch, Daniel Reinhorn, Hovav Nechushtan, Yakir Rottenberg, Philip Blumenfeld

Get full text

Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events by Michal Lotem, Limor Rubin, Aviv Talmon, Yaarit Ribak, David Lavie, Hovav Nechushtan, Nadia Caplan, Oded Shamriz, Irit Adini, Yuval Tal

Get full text

Tumor analysis of BRCA carriers reveals genomic similarities although separated by time by Tal Falick Michaeli, Avital Granit Mizrahi, Batia Azria, Ofra Maymon, Shai Rosenberg, Jonathan Monin, Esther Braitbart Cohen, Myriam Maoz, Luna Kadiuri, Hovav Nechushtan, Amichay Meyrowitz, Tamar Peretz

Get full text

Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slid... by Eli Pikarsky, Anna Elia, Gal Dinstag, Omer Tirosh, Tuvik Beker, Ranit Aharonov, Hovav Nechushtan, Leon Gugel, Yaron Kinar, Michael Tabi, Tzivia Gottlieb, Aron Popovtzer, Johnathan Arnon, Yakir Rottenberg, Philip Blumenfeld

Get full text